Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials
Simon Décary,Maarten de Wit,Florian Naye,Jennifer L Barton,Liana Fraenkel,Linda C Li,Peter Brooks,Dawn Stacey,Lara J Maxwell,Willemina Campbell,Cathie Hofstetter,Marieke Voshaar,Alexa Meara,Robin Christensen,Annelies Boonen,Maria E Suarez-Almazor,Tanya Meade,Lyn March,Janet Elizabeth Jull,Rieke Alten,Esi M Morgan,Glen Stewart Hazlewood,Claire E H Barber,Francis Guillemin,Yasser El-Miedany,Shikha Mittoo,Tiffany Westrich Robertson,Susan J Bartlett,Jasvinder A Singh,Melissa Mannion,Samah Ismail Nasef,Anne Boel,Adewale Adebajo,Laurent Arnaud,Tiffany K Gill,Ellen Moholt,Jennifer Burt,Arundathi Jayatilleke,Ihsane Hmamouchi,Dorthe B Berthelsen,Francisco J Blanco,Kate Mather,Ajesh Maharaj,Saurab Sharma,Francesco Caso,Dorcas Beaton,Beverly Shea,Christopher Fong,Anthony P Fernandez,Sarah Mackie,Elena Nikiphorou,Allyson Jones,Regina Greer-Smith,Victor S Sloan,Akpabio Akpabio,Vibeke Strand,Rebecca R Lee,Valerie Umaefulam,Sara Monti,Nouran Abaza,Grayson Schultz,Simon Stones,Laure Gossec,Sabrina Mai Nielsen,Sabrina Cavallo,Hemalatha Srinivasalu,Deb Constien,Vicki Evans,Peter Tugwell,Karine Toupin-April
DOI: https://doi.org/10.1016/j.semarthrit.2024.152381
Abstract:Objective: To gain consensus on the definitions and descriptions of the domains of the Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials evaluating shared decision making (SDM) interventions. Methods: Following the OMERACT Handbook methods, our Working Group (WG), comprised of 90 members, including 17 patient research partners (PRPs) and 73 clinicians and researchers, had six virtual meetings in addition to email exchanges to develop draft definitions and descriptions. The WG then conducted an international survey of its members to gain consensus on the definitions and descriptions. Finally, the WG members had virtual meetings and e-mail exchanges to review survey results and finalize names, definitions and descriptions of the domains. Results: WG members contributed to developing the definitions. Fifty-two members representing four continents and 13 countries completed the survey, including 15 PRPs, 33 clinicians and 37 researchers. PRPs and clinicians/researchers agreed with all definitions and descriptions with agreements ranging from 87% to 100%. Respondents suggested wording changes to the names, definitions and descriptions to better reflect the domains. Discussions led to further simplification and clarification to address common questions/concerns about the domains. Conclusion: Our WG reached consensus on the definitions and descriptions of the domains of the core domain set for rheumatology trials of SDM interventions. This step is crucial to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set. Clinical significance: The current study provides consensus-based definitions and descriptions for the domains of the OMERACT core domain set for shared decision making interventions from patients/caregivers, clinicians and researchers. This is a crucial step to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set for trials of SDM interventions.